Experience in the use of nafarelin for treatment of benign breast disease.
Roberts
J V
JV
Department of Surgery, King's College Hospital, London, UK.
D000281:Administration, Intranasal; D001940:Breast / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D017274:Nafarelin; D010146:Pain / Q000188:drug therapy*; D010919:Placebos
D010919:Placebos; D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone